BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15080978)

  • 1. N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.
    Burdick DJ; Marsters JC; Aliagas-Martin I; Stanley M; Beresini M; Clark K; McDowell RS; Gadek TR
    Bioorg Med Chem Lett; 2004 May; 14(9):2055-9. PubMed ID: 15080978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.
    Burdick DJ; Paris K; Weese K; Stanley M; Beresini M; Clark K; McDowell RS; Marsters JC; Gadek TR
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1015-8. PubMed ID: 12643901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
    Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.
    Zhong M; Hanan EJ; Shen W; Bui M; Arkin MR; Barr KJ; Evanchik MJ; Hoch U; Hyde J; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):307-10. PubMed ID: 21109434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
    Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary metabolites from marine cyanobacteria and algae inhibit LFA-1/ICAM-1 mediated cell adhesion.
    Takamatsu S; Nagle DG; Gerwick WH
    Planta Med; 2004 Feb; 70(2):127-31. PubMed ID: 14994189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1.
    Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
    Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening leads to the discovery of an effective antagonist of lymphocyte function-associated antigen-1.
    Shoda M; Harada T; Yano K; Stahura FL; Himeno T; Shiojiri S; Kogami Y; Kouji H; Bajorath J
    ChemMedChem; 2007 Apr; 2(4):515-21. PubMed ID: 17340656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding.
    Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW
    Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.
    Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G
    Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determination and correlation of molecular and cellular equilibrium Kd and kinetic k(off) values for small molecule allosteric antagonists of LFA-1.
    Caviness GO; Labadia ME; Giblin PA; Woska JR; Last-Barney K; Jeanfavre DD; Morelock MM
    Biochem Pharmacol; 2007 Jun; 74(1):98-106. PubMed ID: 17482579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion.
    Yusuf-Makagiansar H; Yakovleva TV; Tejo BA; Jones K; Hu Y; Verkhivker GM; Audus KL; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):237-46. PubMed ID: 17718718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
    Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
    J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct quantification of the modulation of interaction between cell- or surface-bound LFA-1 and ICAM-1.
    Vitte J; Pierres A; Benoliel AM; Bongrand P
    J Leukoc Biol; 2004 Sep; 76(3):594-602. PubMed ID: 15240749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1.
    Wattanasin S; Kallen J; Myers S; Guo Q; Sabio M; Ehrhardt C; Albert R; Hommel U; Weckbecker G; Welzenbach K; Weitz-Schmidt G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1217-20. PubMed ID: 15686945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic control of allosteric antagonism of leukocyte function antigen-1 and intercellular adhesion molecule-1 interaction.
    Nam K; Maiorov V; Feuston B; Kearsley S
    Proteins; 2006 Aug; 64(2):376-84. PubMed ID: 16705652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geometrical and conformational preferences of the 9-fluorenylmethoxycarbonyl-amino moiety.
    Broda MA; Mazur L; Kozioł AE; Rzeszotarska B
    J Pept Sci; 2004 Jul; 10(7):448-61. PubMed ID: 15298180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.
    Wu JP; Emeigh J; Gao DA; Goldberg DR; Kuzmich D; Miao C; Potocki I; Qian KC; Sorcek RJ; Jeanfavre DD; Kishimoto K; Mainolfi EA; Nabozny G; Peng C; Reilly P; Rothlein R; Sellati RH; Woska JR; Chen S; Gunn JA; O'Brien D; Norris SH; Kelly TA
    J Med Chem; 2004 Oct; 47(22):5356-66. PubMed ID: 15481974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.